Portal de Murcia
www.portaldemurcia.com
This recognition has been granted by the Scientific Committee of the Royal Academy of Veterinary Sciences of Spain for its informative research about the therapies with stem cells that currently exist in the field of animal medicine
The award-winning work has been led by the professor of Medicine and Animal Surgery Jesús Talavera, includes a literature review on cell therapy both from a theoretical section that defines exactly what the stem cells are and what is their application, to an eminently practical which includes the clinical contributions that currently have scientific support.
This research has been published in the journal of the Association of Spanish Small Animal Veterinarians (AVEPA), Veterinary Clinic of Small Animals, a publication widely disseminated among professionals dedicated to medicine in this field.
In it, stem cells are defined as those with properties of self-renewal and differentiation to cells of different lineages.
Their identification has brought new hopes to the field of science in the face of diseases in which conventional therapies proved insufficient.
That is why the UMU researchers with this review intend to provide the clinical veterinarian interested in these types of therapies with a basic knowledge that will help them decide whether or not to offer their patients this therapeutic option.
"Our work has reviewed the existing literature on stem cell treatments, focusing on studies that have included veterinary patients, not those performed in experimental settings," says Talavera.
"This is one of the most important differences: the veterinary clinician interested in applying these therapies to his patients is interested in knowing what scientific evidence exists about the potential benefits in real patients with spontaneous diseases, not experimentally induced."
The clinical interest of stem cells is based on their regenerative potential for ligament and tendon repair, bone regeneration or osteoarthritis, a common joint disease in pets.
We also review the evidence of clinical benefit in neuromuscular diseases, heart disease, cutaneous, renal, digestive and ocular diseases.
This award was given last January 15 at the headquarters of the Royal Academy of Veterinary Sciences sponsored by the international pharmaceutical Boehringer Ingelheim and endowed with € 2,000.
Source: Universidad de Murcia
Privacy policy
- Legal notice
- Cookies